SS
TGTX icon

Sunbelt Securities’s TG Therapeutics TGTX Stock Holding History

Sunbelt Securities’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$797 Buy
24
+23
+2,300% +$685 ﹤0.01% 2158
2025
Q4 		$30 Sell
1
-1
-50% -$33 ﹤0.01% 2698
2025
Q3 		$72 Buy
+2
New +$66 ﹤0.01% 2547

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Sunbelt Securities's TGTX Position: Q1 2026 in Review

Sunbelt Securities increased its TG Therapeutics (TGTX) stake by 2,300% in Q1 2026, buying an estimated $685 and bringing the position to 24 shares worth $797. The position accounts for ﹤0.01% of the portfolio, ranked #2158.

Sunbelt Securities first reported a position in TGTX in Q3 2025 and has held it in 3 quarters since. 364 funds tracked by Wall St. Rank hold TGTX as of Q1 2026.

  • Sunbelt Securities held 24 shares of TG Therapeutics worth $797 as of Q1 2026.
  • Sunbelt Securities bought 23 TG Therapeutics shares in Q1 2026, an estimated $685.
  • TG Therapeutics made up ﹤0.01% of Sunbelt Securities's portfolio in Q1 2026, its #2158 holding.
  • Sunbelt Securities first reported a position in TG Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • 364 funds tracked by Wall St. Rank held TG Therapeutics as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.